Call for Proposals: Anti-Osteoclastic Drugs and Their Impact on Maxillofacial and Orthopedic Bone Biology, Disease, Diagnosis, Prevention, Surgery, and Treatment Modalities

Call for Proposals: Anti-Osteoclastic Drugs and Their Impact on Maxillofacial and Orthopedic Bone Biology, Disease, Diagnosis, Prevention, Surgery, and Treatment Modalities The AOCMF R&D Commission invites you to submit your proposals in the research field of 'Anti-osteoclastic drugs and their impact on maxillofacial and orthopedic bone biology, disease, diagnosis, prevention, surgery, and treatment modalities (ARONJ)'. The second call for proposals is now open. Please ensure that you send in your proposals at the very latest by September 30, 2014. Research questions The risks of the exposure to these medications with regard to the outcome of orthopedic, oral and maxillofacial procedures is not well established and has only been reported in case series. Optimal means of treating fractures, managing infection, performing ablative surgery or reconstructing patients with exposure to these drugs has not been established. For example: -- Is vascularized tissue transfer beneficial in jaw bone reconstruction in this subgroup? -- Can free grafts be used in trauma reconstruction in the patient exposed to these drugs? -- Should bone fixation be modified in fractures occurring in patients taking anti-osteoclastic drugs Focus The focus of the research projects includes prevention of anti-osteoclastic drug osteonecrosis of the jaw (ARONJ) as well as treatment modalities and risk factors The proposed projects: - May be ep...
Source: ScanGrants feed - Category: Research Authors: Source Type: funding